AndrewMarkScharenbergMD

Pediatrics • Seattle, WA

Pediatric Allergy

Professor, Pediatrics, University of Washington School of Medicine

Join to view full profile

Dr. Scharenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Scharenberg's full profile

Already have an account?

Office
4800 Sand Point Way Ne
Seattle, WA 98105
Phone+1 206-987-2000

Education & Training

University of North Carolina HospitalsResidency, Pediatrics, 1990 - 1992
University of North Carolina at Chapel Hill School of MedicineClass of 1990

Certifications & Licensure

WA State Medical License 2000 - 2025
MA State Medical License 1995 - 2000
DC State Medical License 1993 - 1997
MD State Medical License 1993 - 1995
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2008

Clinical Trials

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Start of enrollment: 2016 Aug 17
Suspended
Phase 1, Phase 2

Publications & Presentations

PubMed

8 citations
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells.
Peter J Cook, Su Jung Yang, Gene I Uenishi, Annaiz Grimm, Samuel E West
Molecular Therapy. 2023-08-02
25 citations
Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases
Moritz Schmidt, Ashish Gupta, Christien Bednarski, Stefanie Gehrig-Giannini, Florian Richter
Nature Communications. 2021-07-09
71 citations
Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function.
Honaker Yuchi Chiang, Nicholas Hubbard, Yufei Xiang, Logan Fisher, David Hagin
Science Translational Medicine. 2020-06-03

Abstracts/Posters

Enabling Gene-Edited, Regulatory-like, T Cells (edTreg) for Treatment of IPEX and Other Autoimmune Disorders
Andrew M. Scharenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Chemically Controlled, Immunosuppression-Resistant, Anti-Bcma CAR-T Cells for Treatment of Antibody-Mediated Autoimmunity
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy OfficerJune 8th, 2021
Casebia Advances Genetic Engineering with New Tools and TechniquesApril 24th, 2019
Alpine Immune Sciences Advances Oncology Programs with New ALPN-202 Preclinical Data and Key Additions to Scientific Advisory BoardNovember 9th, 2018
Join now to see all